ATE401342T1 - Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden - Google Patents
Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schädenInfo
- Publication number
- ATE401342T1 ATE401342T1 AT99950055T AT99950055T ATE401342T1 AT E401342 T1 ATE401342 T1 AT E401342T1 AT 99950055 T AT99950055 T AT 99950055T AT 99950055 T AT99950055 T AT 99950055T AT E401342 T1 ATE401342 T1 AT E401342T1
- Authority
- AT
- Austria
- Prior art keywords
- albumin
- marker
- measurement
- detection
- detecting
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000009027 Albumins Human genes 0.000 abstract 6
- 108010088751 Albumins Proteins 0.000 abstract 6
- 239000003550 marker Substances 0.000 abstract 5
- 150000003254 radicals Chemical class 0.000 abstract 5
- 238000005259 measurement Methods 0.000 abstract 4
- 230000004075 alteration Effects 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 3
- 229910017052 cobalt Inorganic materials 0.000 abstract 2
- 239000010941 cobalt Substances 0.000 abstract 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 108010036999 aspartyl-alanyl-histidyl-lysine Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000003636 chemical group Chemical group 0.000 abstract 1
- 229940121657 clinical drug Drugs 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000010324 immunological assay Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000011896 sensitive detection Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Sampling And Sample Adjustment (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating And Analyzing Materials By Characteristic Methods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10296298P | 1998-10-02 | 1998-10-02 | |
| US09/165,961 US6475743B1 (en) | 1998-10-02 | 1998-10-02 | Marker useful for detection and measurement of free radical damage and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401342T1 true ATE401342T1 (de) | 2008-08-15 |
Family
ID=26799929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99950055T ATE401342T1 (de) | 1998-10-02 | 1999-10-01 | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1117686B1 (de) |
| AT (1) | ATE401342T1 (de) |
| AU (1) | AU6279399A (de) |
| DE (1) | DE69939121D1 (de) |
| WO (1) | WO2000020454A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6492179B1 (en) | 1998-10-02 | 2002-12-10 | Ischemia Techologies, Inc. | Test for rapid evaluation of ischemic states and kit |
| US6461875B1 (en) | 1998-10-02 | 2002-10-08 | Ischemia Technologies, Inc. | Test for rapid evaluation of ischemic states and kit |
| AU769727B2 (en) * | 1998-10-02 | 2004-02-05 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
| US7449338B2 (en) | 1998-10-02 | 2008-11-11 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
| US7070937B1 (en) | 1998-10-02 | 2006-07-04 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
| US7297544B2 (en) | 1998-10-02 | 2007-11-20 | Ischemia Technologies, Inc. | Tests for the rapid evaluation of ischemic states and kits |
| US6475743B1 (en) | 1998-10-02 | 2002-11-05 | Ischemia Technologies, Inc. | Marker useful for detection and measurement of free radical damage and method |
| US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
| US7829072B2 (en) | 2000-07-14 | 2010-11-09 | Carter Daniel C | Serum albumin compositions for use in cleansing or dermatological products for skin or hair |
| US6787636B1 (en) | 2000-07-14 | 2004-09-07 | New Century Pharmaceuticals, Inc. | Modified serum albumin with reduced affinity for nickel and copper |
| CN100553636C (zh) | 2000-08-04 | 2009-10-28 | Dmi生物科学公司 | 二酮基哌嗪和包含它们的组合物的使用方法 |
| EP1401322A4 (de) * | 2001-05-30 | 2004-11-10 | Ischemia Tech Inc | Verfahren und system für die optische durchführung eines assays zur bestimmung eines medizinischen leidens |
| JP2005510712A (ja) | 2001-11-26 | 2005-04-21 | イスケミア・テクノロジーズ・インコーポレーテッド | 虚血の電気化学的検知 |
| JP4674317B2 (ja) | 2002-10-02 | 2011-04-20 | ディエムアイ アクイジション コーポレイション | 疾病の判定および監視 |
| EP2386862A1 (de) * | 2002-10-09 | 2011-11-16 | DMI Biosciences, Inc. | Verfahren und Kits zur Diagnose von Blinddarmentzündung |
| EP2517718B1 (de) | 2003-05-15 | 2016-03-02 | Ampio Pharmaceuticals, Inc. | Behandlung von T-Zell-vermittelten Krankheiten |
| US7074194B2 (en) | 2003-05-19 | 2006-07-11 | Ischemia Technologies, Inc. | Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
| CA2846464A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| ES2795803T3 (es) | 2011-10-10 | 2020-11-24 | Ampio Pharmaceuticals Inc | Tratamiento de artropatía degenerativa |
| HK1198812A1 (en) | 2011-10-28 | 2015-06-12 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| EP4066836A1 (de) | 2014-08-18 | 2022-10-05 | Ampio Pharmaceuticals, Inc. | Behandlung von gelenkerkrankungen |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
-
1999
- 1999-10-01 DE DE69939121T patent/DE69939121D1/de not_active Revoked
- 1999-10-01 WO PCT/US1999/022746 patent/WO2000020454A1/en not_active Ceased
- 1999-10-01 AT AT99950055T patent/ATE401342T1/de not_active IP Right Cessation
- 1999-10-01 AU AU62793/99A patent/AU6279399A/en not_active Abandoned
- 1999-10-01 EP EP99950055A patent/EP1117686B1/de not_active Revoked
Also Published As
| Publication number | Publication date |
|---|---|
| DE69939121D1 (de) | 2008-08-28 |
| WO2000020454A1 (en) | 2000-04-13 |
| AU6279399A (en) | 2000-04-26 |
| EP1117686B1 (de) | 2008-07-16 |
| EP1117686A1 (de) | 2001-07-25 |
| EP1117686A4 (de) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE401342T1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| US5585277A (en) | Screening method for identifying ligands for target proteins | |
| DE69607176T2 (de) | Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper | |
| DE60118527D1 (de) | Sensible und multiplexe diagnostische tests zur proteinanalyse | |
| CA2480466A1 (en) | Detection and/or monitoring of synuclein-related diseases | |
| RU95108591A (ru) | Способ определения состояния сепсисного заболевания | |
| WO2002082075A3 (de) | Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien | |
| Friedman | Comparison of four different silver-staining techniques for salivary protein detection in alkaline polyacrylamide gels | |
| JP2007533985A5 (de) | ||
| EP3102593B1 (de) | Fluorometrischer immunoassay zum nachweis von anti-dsdna-antikörpern | |
| DE60025170D1 (de) | Diagnostisches verfahren für asthma | |
| Dukhanina et al. | Spectral studies on the calcium-binding properties of Mts1 protein and its interaction with target protein | |
| CN111656191B (zh) | 用于鉴别病毒性感染与细菌性感染的方法和设备 | |
| AU5141798A (en) | Methods and reagents for determining protein s | |
| CA2366651A1 (en) | A method for detecting megsin protein and use thereof | |
| BR0111975A (pt) | Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator | |
| AU2007200433B8 (en) | Biomolecular toxicity assay | |
| WO1999045388A1 (en) | Test for analyzing a sample | |
| JPS5995460A (ja) | リューマチ性疾病の検査方法および試験キット | |
| CA2344762A1 (en) | Tests for the rapid evaluation of ischemic states and kits | |
| WO2004054431A3 (en) | Tests for the rapid evaluation of ischemic states and kits | |
| DE60216482D1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
| WO2007051605A2 (de) | Verfahren zur bestimmung der spaltbarkeit von substraten | |
| Yu et al. | Determination of CKMB activity and protein concentration and their application in the diagnosis of AMI | |
| WILLAN et al. | and XRPC 25 by Spin-Label Mapping |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |